Fennec Pharmaceuticals Q1 2026 Earnings EPS Surprise Beats Estimates Amidst PreRevenue Stage Odysightai Inc ODYS Q1 2026 Earnings EPS Miss but Positive Stock Reaction Signals Investor Confidence FSEA Q3 2024 Earnings Modest Profitability Achieved Amidst Challenging Environment PHVS Q1 2026 Earnings NarrowerThanExpected Loss as Biotech Advances HAE Pipeline EPAC Q1 2026 Earnings EPS Falls Slightly Short of Estimates Shares Edge Higher KGS Q1 2026 Earnings EPS Surges Past Estimates as Operational Efficiency Improves